Sage Therapeutics, Inc. is a pharmaceutical company based in Cambridge, MA, specializing in the development of innovative treatments for brain health disorders. With a distinct approach to neuroscience drug development, Sage aims to discover new pathways to brain health by creating medicines that make a meaningful impact on patients' lives. Their portfolio includes market-leading products for postpartum depression and major depressive disorder, as well as ongoing clinical trials for a range of conditions such as Huntington's disease, Parkinson's disease, and Alzheimer's disease.
Committed to putting patients and their families first, Sage is rethinking care delivery and advocating for patient support through their patient advocacy programs. With a focus on collaboration and partnerships, Sage works with leading biopharmaceutical companies to advance their drug candidates and address the unmet treatment needs of patients. Through their dedication to innovation and research, Sage Therapeutics is striving to improve the lives of individuals affected by brain health disorders.
Generated from the website